Citations (158)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Meng Xiao, Xu Wang, Ming Yan & Wantao Chen. (2016) A systematic evaluation for the potential translation of CD166-related expression as a cancer biomarker. Expert Review of Molecular Diagnostics 16:9, pages 925-932.
Read now
Read now
Jens Neumann, Lisa Löhrs, Markus Albertsmeier, Simone Reu, Markus Guba, Jens Werner, Thomas Kirchner & Martin Angele. (2015) Cancer Stem Cell Markers Are Associated With Distant Hematogenous Liver Metastases But Not With Peritoneal Carcinomatosis in Colorectal Cancer. Cancer Investigation 33:8, pages 354-360.
Read now
Read now
L Florianova, M Orain, B Têtu & CJ Doillon. (2013) Histological study of stem-like cells in human colon adenocarcinoma at different stages of the disease. Biotechnic & Histochemistry 88:5, pages 222-234.
Read now
Read now
Atique U Ahmed, Brenda Auffinger & Maciej S Lesniak. (2013) Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies. Expert Review of Neurotherapeutics 13:5, pages 545-555.
Read now
Read now
Luca Reggiani Bonetti, Mario Migaldi, Emanuele Caredda, Alma Boninsegna, Maurizio Ponz De Leon, Carmela Di Gregorio, Valeria Barresi, Domenico Scannone, Silvio Danese, Achille Cittadini & Alessandro Sgambato. (2012) Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients. Scandinavian Journal of Gastroenterology 47:10, pages 1211-1217.
Read now
Read now
Articles from other publishers (153)
Mia C. Borlongan, Dipongkor Saha & Hongbin Wang. (2023) Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy. Stem Cell Reviews and Reports.
Crossref
Crossref
O. I. Kovalev, S. V. Vtorushin & E. V. Kaigorodova. (2023) Stem cell properties of cancer cells in ascitic fluid of patients with ovarian cancer: a key to control over cancer progression. Bulletin of Siberian Medicine 22:2, pages 122-133.
Crossref
Crossref
Nassiba Taib, Maysaloun Merhi, Varghese Inchakalody, Sarra Mestiri, Shereena Hydrose, Karama Makni-Maalej, Afsheen Raza, Fairooz Sahir, Fouad Azizi, Parveen B. Nizamuddin, Queenie Fernandes, Zeenath Safira K. M. Yoosuf, Salam Almoghrabi, Lobna Al-Zaidan, Alaaeldin Shablak, Shahab Uddin, Cristina Maccalli, Mohammed Ussama Al Homsi & Said Dermime. (2023) Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy. Journal of Translational Medicine 21:1.
Crossref
Crossref
Hassan Ehteram, Fatemeh Aslanbeigi, Ebrahim Ghoochani Khorasani, Mohammad Tolouee & Hamed Haddad Kashani. (2022) Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients with Colon Cancer. Oncology and Therapy 10:2, pages 451-461.
Crossref
Crossref
Shibnath Ghatak, Vincent C. Hascall, Nikos Karamanos, Roger R. Markwald & Suniti Misra. (2022) Chemotherapy induces feedback up-regulation of CD44v6 in colorectal cancer initiating cells through β-catenin/MDR1 signaling to sustain chemoresistance. Frontiers in Oncology 12.
Crossref
Crossref
Irina Florina Cherciu Harbiyeli, Daniela Elena Burtea, Elena Tatiana Ivan, Ioana Streață, Elena Raluca Nicoli, Daniel Uscatu, Mircea-Sebastian Șerbănescu, Mihai Ioana, Peter Vilmann & Adrian Săftoiu. (2022) Assessing Putative Markers of Colorectal Cancer Stem Cells: From Colonoscopy to Gene Expression Profiling. Diagnostics 12:10, pages 2280.
Crossref
Crossref
Chin Ngok Chu & Terence Kin Wah Lee. (2022) Targeting protein kinases in cancer stem cells. Essays in Biochemistry 66:4, pages 399-412.
Crossref
Crossref
Sandra Mersakova, Katarina Janikova, Michal Kalman, Juraj Marcinek, Marian Grendar, Martin Vojtko, Roman Kycina, Miroslav Pindura, Jan Janik, Peter Mikolajcik, Eva Gabonova, Ludovit Laca, Ester Mejstrikova, Erika Halasova, Jan Strnadel & Zora Lasabova. (2022) Cancer stem cell marker expression and methylation status in patients with colorectal cancer. Oncology Letters 24:1.
Crossref
Crossref
Marta Sánchez-Díez, Nicolás Alegría-Aravena, Marta López-Montes, Josefa Quiroz-Troncoso, Raquel González-Martos, Adrián Menéndez-Rey, José Luis Sánchez-Sánchez, Juan Manuel Pastor & Carmen Ramírez-Castillejo. (2022) Implication of Different Tumor Biomarkers in Drug Resistance and Invasiveness in Primary and Metastatic Colorectal Cancer Cell Lines. Biomedicines 10:5, pages 1083.
Crossref
Crossref
Mehran Pashirzad, Thozhukat Sathyapalan, Afsana Sheikh, Prashant Kesharwani & Amirhossein Sahebkar. (2022) Cancer stem cells: An overview of the pathophysiological and prognostic roles in colorectal cancer. Process Biochemistry 115, pages 19-29.
Crossref
Crossref
Elham Kalantari, Tahereh Taheri, Saba Fata, Maryam Abolhasani, Mitra Mehrazma, Zahra Madjd & Mojgan Asgari. (2022) Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer. World Journal of Surgical Oncology 20:1.
Crossref
Crossref
Ting-Yu Chang, Cheng-Tien Wu, Meei-Ling Sheu, Rong-Sen Yang & Shing-Hwa Liu. (2021) CARMA3 Promotes Colorectal Cancer Cell Motility and Cancer Stemness via YAP-Mediated NF-κB Activation. Cancers 13:23, pages 5946.
Crossref
Crossref
Pelin Balcik-Ercin, Laure Cayrefourcq, Rama Soundararajan, Sendurai A. Mani & Catherine Alix-Panabières. (2021) Epithelial-to-Mesenchymal Plasticity in Circulating Tumor Cell Lines Sequentially Derived from a Patient with Colorectal Cancer. Cancers 13:21, pages 5408.
Crossref
Crossref
Imelda Rey, Agung Putra, Dharma Lindarto & Fauzi Yusuf. (2021) Relationship between CD 163 Tumor-Associated Macrophages and Colorectal-Cancer Stem Cell Markers. Open Access Macedonian Journal of Medical Sciences 9:B, pages 1381-1386.
Crossref
Crossref
Fátima Ferragut, Vanina S. Vachetta, María F. Troncoso, Gabriel A. Rabinovich & María T. Elola. (2021) ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression. Cytokine & Growth Factor Reviews 61, pages 27-37.
Crossref
Crossref
Athanasios Patsalias & Zuzana Kozovska. (2021) Personalized medicine: Stem cells in colorectal cancer treatment. Biomedicine & Pharmacotherapy 141, pages 111821.
Crossref
Crossref
Wookyeom Yang, Dasol Kim, Dae Kyoung Kim, Kyung Un Choi, Dong Soo Suh & Jae Ho Kim. (2021) Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells. International Journal of Molecular Sciences 22:10, pages 5059.
Crossref
Crossref
Jaceline Gisliane Pires Sanches, Bo Song, Qingqing Zhang, Xinye Cui, Iddrisu Baba Yabasin, Michael Ntim, Xinlong Li, Jiabei He, Yao Zhang, Jun Mao, Ying Lu & Lianhong Li. (2021) The Role of KDM2B and EZH2 in Regulating the Stemness in Colorectal Cancer Through the PI3K/AKT Pathway. Frontiers in Oncology 11.
Crossref
Crossref
A. B. Sagakyants, O. I. Kit, E. P. Ulyanova, E. Yu. Zlatnik, I. A. Novikova, O. G. Shulgina, Yu. A. Gevorkyan, N. V. Soldatkina, N. S. Samoylenko, E. A. Dzhenkova & A. V. Shaposhnikov. (2021) FEATURES OF EXPRESSION OF CD133 AND CD44 MARKERS OF TUMOR STEM CELLS WITH METASTATIC AND NON-METASTATIC GASTRIC CANCER. Siberian journal of oncology 20:1, pages 97-104.
Crossref
Crossref
Tengyang Ni, Haibo Wang, Dongmei Zhan, Li Tao, Mengying Lv, Weimin Wang, Zewen Chu, Zhen Zhou, Masataka Sunagawa & Yanqing Liu. (2021) CD133+/CD166+ human gastric adenocarcinoma cells present the properties of neoplastic stem cells and emerge more malignant features. Life Sciences 269, pages 119021.
Crossref
Crossref
Afnan H. El‐Gowily & Mohammed A. Abosheasha. (2020) Differential mechanisms of autophagy in cancer stem cells: Emphasizing gastrointestinal cancers. Cell Biochemistry and Function 39:2, pages 162-173.
Crossref
Crossref
Shibnath Ghatak, Vincent C. Hascall, Roger R. Markwald & Suniti Misra. (2021) FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells. International Journal of Molecular Sciences 22:2, pages 753.
Crossref
Crossref
Xiaohui Wang, Wei Qiu, Haoyu Liu, Tian Li, Hua Ye, Yateng Li, Xiang Xu & Ping Chen. (2020) The prognostic value of combining CD133 and mismatch repair proteins in patients with colorectal cancer. Clinical and Experimental Pharmacology and Physiology 48:1, pages 54-63.
Crossref
Crossref
Siao-Syun Guan, Cheng-Tien Wu, Tse-Zung Liao, Tsai-Yueh Luo, Kun-Liang Lin & Shing-Hwa Liu. (2020) Indium-111-labeled CD166-targeted peptide as a potential nuclear imaging agent for detecting colorectal cancer stem-like cells in a xenograft mouse model. EJNMMI Research 10:1.
Crossref
Crossref
Ryouichi Tsunedomi, Kiyoshi Yoshimura, Nobuaki Suzuki, Shoichi Hazama & Hiroaki Nagano. (2020) Clinical implications of cancer stem cells in digestive cancers: acquisition of stemness and prognostic impact. Surgery Today 50:12, pages 1560-1577.
Crossref
Crossref
Rubén A. Bartolomé, Laura Pintado-Berninches, Marta Jaén, Vivian de Los Ríos, Juan Ignacio Imbaud & J. Ignacio Casal. (2020) SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166. Oncogene 39:38, pages 6085-6098.
Crossref
Crossref
Ling Wang, Ke Deng, Liang Gong, Liang Zhou, Sapna Sayed, Huan Li, Qi Sun, Zijie Su, Zhongyuan Wang, Shanshan Liu, Huifang Zhu, Jiaxing Song & Desheng Lu. (2020) Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity. Pharmacological Research 159, pages 104955.
Crossref
Crossref
Diana Pádua, Paula Figueira, Inês Ribeiro, Raquel Almeida & Patrícia Mesquita. (2020) The Relevance of Transcription Factors in Gastric and Colorectal Cancer Stem Cells Identification and Eradication. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Ognen Kostovski, Svetozar Antovic, Gjorgji Trajkovski, Irena Kostovska, Rubens Jovanovic & Nikola Jankulovski. (2020) High expression of CD133 – stem cell marker for
prediction of clinically agressive type of colorectal cancer. Polish Journal of Surgery 92:3, pages 9-14.
Crossref
Crossref
Xiaoshan ZhangAping YuanXueru ZhaoZhenfeng LiGuanglin Cui. (2020) Tumoral Expression of CD166 in Human Esophageal Squamous Cell Carcinoma: Implications for Cancer Progression and Prognosis. Cancer Biotherapy and Radiopharmaceuticals 35:3, pages 214-222.
Crossref
Crossref
He Zhou, Yongfu Xiong, Linglong Peng, Rong Wang, Hairong Zhang & Zhongxue Fu. (2019) LncRNA‐cCSC1 modulates cancer stem cell properties in colorectal cancer via activation of the Hedgehog signaling pathway. Journal of Cellular Biochemistry 121:3, pages 2510-2524.
Crossref
Crossref
Manali Haniti Mohd-Zahid, Rohimah Mohamud, Che Azurahanim Che Abdullah, JitKang Lim, Halima Alem, Wan Nurhidayah Wan Hanaffi & Iskandar Z. A.. (2020) Colorectal cancer stem cells: a review of targeted drug delivery by gold nanoparticles. RSC Advances 10:2, pages 973-985.
Crossref
Crossref
Ji Young Chang, Jae Hyun Kim, Joyeon Kang, Yehyun Park, Soo Jung Park, Jae Hee Cheon, Won Ho Kim, Hoguen Kim, Jae Jun Park & Tae Il Kim. (2020) mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer. Yonsei Medical Journal 61:7, pages 572.
Crossref
Crossref
Namasivayam Nalini & Bichandarkoil Jayaram Pratima. 2020. Cancer Stem Cells: New Horizons in Cancer Therapies. Cancer Stem Cells: New Horizons in Cancer Therapies
51
67
.
Heena Jariyal, Chanchal Gupta, Vedika Sandeep Bhat, Jayant Ramakant Wagh & Akshay Srivastava. (2019) Advancements in Cancer Stem Cell Isolation and Characterization. Stem Cell Reviews and Reports 15:6, pages 755-773.
Crossref
Crossref
Audrey Vincent, Aïcha Ouelkdite-Oumouchal, Mouloud Souidi, Julie Leclerc, Bernadette Neve & Isabelle Van Seuningen. (2019) Colon cancer stemness as a reversible epigenetic state: Implications for anticancer therapies. World Journal of Stem Cells 11:11, pages 920-936.
Crossref
Crossref
Kenta Tsunekuni, Masamitsu Konno, Naotsugu Haraguchi, Jun Koseki, Ayumu Asai, Kazuaki Matsuoka, Takashi Kobunai, Teiji Takechi, Yuichiro Doki, Masaki Mori & Hideshi Ishii. (2019) CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure. Scientific Reports 9:1.
Crossref
Crossref
Maryam Akbarzadeh, Nazila Fathi Maroufi, Abbas Pirpour Tazehkand, Moloud Akbarzadeh, Sepideh Bastani, Reza Safdari, Ali Farzane, Amir Fattahi, Hamid Reza Nejabati, Mohammad Nouri & Nasser Samadi. (2019) Current approaches in identification and isolation of cancer stem cells. Journal of Cellular Physiology 234:9, pages 14759-14772.
Crossref
Crossref
Xia Chu, Yiqi Xue, Xinying Huo, Jingsun Wei, Yuetong Chen, Rongbo Han, Hong Chen, Xinyu Su, Honghong Zhang, Yang Gong & Jinfei Chen. (2019) Establishment and characterization of a novel cell line (cc‑006cpm8) of moderately/poorly differentiated colorectal adenocarcinoma derived from a primary tumor of a patient. International Journal of Oncology.
Crossref
Crossref
Seyed Mostafa Parizadeh, Reza Jafarzadeh-Esfehani, Seyed Mahdi Hassanian, Seyed Mohammad Reza Parizadeh, Samaneh Vojdani, Maryam Ghandehari, Anahita Ghazaghi, Majid Khazaei, Soodabeh Shahidsales, Majid Rezayi, Fereshteh Asgharzadeh, Majid Ghayour-Mobarhan, Gordon A. Ferns & Amir Avan. (2019) Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer. The International Journal of Biochemistry & Cell Biology 110, pages 75-83.
Crossref
Crossref
Zhenpeng Wang, Yufei Tang, Lei Xie, Aiping Huang, Chunchun Xue, Zhen Gu, Kaiqiang Wang & Shaoqi Zong. (2019) The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis. Frontiers in Oncology 9.
Crossref
Crossref
Asieh Sadeghi, Raheleh Roudi, Alireza Mirzaei, Ali Zare Mirzaei, Zahra Madjd & Maryam Abolhasani. (2019) CD44 epithelial isoform inversely associates with invasive characteristics of colorectal cancer. Biomarkers in Medicine 13:6, pages 419-426.
Crossref
Crossref
Chitra Joseph, Maariya Arshad, Sasagu Kurozomi, Maryam Althobiti, Islam M. Miligy, Sara Al-izzi, Michael S. Toss, Fang Qin Goh, Simon J. Johnston, Stewart G. Martin, Ian O. Ellis, Nigel P. Mongan, Andrew R. Green & Emad A. Rakha. (2018) Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer. Breast Cancer Research and Treatment 174:2, pages 387-399.
Crossref
Crossref
Said Abdullah Khelwatty, Sharadah Essapen, Izhar Bagwan, Margaret Green, Alan M. Seddon & Helmout Modjtahedi. (2019) Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer. Oncotarget 10:18, pages 1704-1715.
Crossref
Crossref
Joey H. Li, Ross H. McMillan, Asma Begum, Christian B. Gocke & William Matsui. (2019) IQGAP1 Maintains Pancreatic Ductal Adenocarcinoma Clonogenic Growth and Metastasis. Pancreas 48:1, pages 94-98.
Crossref
Crossref
Geou-Yarh Liou. (2019) CD133 as a regulator of cancer metastasis through the cancer stem cells. The International Journal of Biochemistry & Cell Biology 106, pages 1-7.
Crossref
Crossref
Paige M. Glumac & Aaron M. LeBeau. (2018) The role of CD133 in cancer: a concise review. Clinical and Translational Medicine 7:1.
Crossref
Crossref
Yan-Feng Huang, Wen-Bo Niu, Rong Hu, Ling-Jun Wang, Zeng-Yan Huang, Shi-Hao Ni, Ming-Qing Wang, Yi Yang, Yu-Sheng Huang, Wen-Jun Feng, Wei Xiao, Da-Jian Zhu, Shao-Xiang Xian & Lu Lu. (2018) FIBP knockdown attenuates growth and enhances chemotherapy in colorectal cancer via regulating GSK3β-related pathways. Oncogenesis 7:9.
Crossref
Crossref
Sara Soltanian, Helia Riahirad, Athareh Pabarja, Elham Jafari & Behjat Kalantari Khandani. (2018) Effect of Cinnamic acid and FOLFOX in diminishing side population and downregulating cancer stem cell markers in colon cancer cell line HT-29. DARU Journal of Pharmaceutical Sciences 26:1, pages 19-29.
Crossref
Crossref
Rongyong Huang, Dan Mo, Junrong Wu, Huaying Ai & Yiping Lu. (2018) CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients. Medicine 97:23, pages e10446.
Crossref
Crossref
Esra Aydemir Çoban & Fikrettin Şahin. 2018. Cell Biology and Translational Medicine, Volume 2. Cell Biology and Translational Medicine, Volume 2
97
113
.
Xiaofeng Yu, Lin Mi, Jie Dong & Jian Zou. (2017) Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a “sponge” against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells. BMC Cancer 17:1.
Crossref
Crossref
T.J. Miller, M.J. McCoy, C. Hemmings, M.K. Bulsara, B. Iacopetta & C.F. Platell. (2017) The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3. Pathology 49:7, pages 721-730.
Crossref
Crossref
Ahad Mokhtarzadeh, Soodabeh Hassanpour, Zahra Farajzadeh Vahid, Maryam Hejazi, Maryam Hashemi, Javad Ranjbari, Maryam Tabarzad, Saeed Noorolyai & Miguel de la Guardia. (2017) Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers. Journal of Controlled Release 266, pages 166-186.
Crossref
Crossref
Rizwan Ahmad, Balawant Kumar, Kaichao Pan, Punita Dhawan & Amar B. Singh. (2017) HDAC-4 regulates claudin-2 expression in EGFR-ERK1/2 dependent manner to regulate colonic epithelial cell differentiation. Oncotarget 8:50, pages 87718-87736.
Crossref
Crossref
Susu Han, Wei Yang, Shaoqi Zong, Hongjia Li, Shanshan Liu, Wen Li, Qi Shi & Fenggang Hou. (2017) Clinicopathological, prognostic and predictive value of CD166 expression in colorectal cancer: a meta-analysis. Oncotarget 8:38, pages 64373-64384.
Crossref
Crossref
Yong Yang, Guoxin Wang, Dajian Zhu, Yanfeng Huang, Yong Luo, Pengfei Su, Xiaowu Chen & Qian Wang. (2017) Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer. International Journal of Oncology 51:2, pages 515-524.
Crossref
Crossref
Yeqing Zhang, Chunmei Qian, Lin Jing, Jianlin Ren & Yu Guan. (2017) Meta-analysis indicating that high ALCAM expression predicts poor prognosis in colorectal cancer. Oncotarget 8:29, pages 48272-48281.
Crossref
Crossref
Norashikin Zakaria, Nazilah Abdul Satar, Noor Hanis Abu Halim, Siti Hawa Ngalim, Narazah Mohd Yusoff, Juntang Lin & Badrul Hisham Yahaya. (2017) Targeting Lung Cancer Stem Cells: Research and Clinical Impacts. Frontiers in Oncology 7.
Crossref
Crossref
Laura Devis, Cristian P Moiola, Nuria Masia, Elena Martinez-Garcia, Maria Santacana, Tomita Vasilica Stirbat, Françoise Brochard-Wyart, Ángel García, Francesc Alameda, Silvia Cabrera, Jose Palacios, Gema Moreno-Bueno, Miguel Abal, William Thomas, Sylvie Dufour, Xavier Matias-Guiu, Anna Santamaria, Jaume Reventos, Antonio Gil-Moreno & Eva Colas. (2017) Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer. The Journal of Pathology 241:4, pages 475-487.
Crossref
Crossref
Alireza Mirzaei, Zahra Madjd, Azade Amini Kadijani, Samaneh Alinaghi, Abolfazl Akbari & Gholamreza Tavoosidana. (2017) Cancer Stem Cell’s Potential Clinical Implications. Iranian Journal of Cancer Prevention In Press:In Press.
Crossref
Crossref
Tianhui Pan, Jinghong Xu & Yongliang Zhu. (2017) Self-renewal molecular mechanisms of colorectal cancer stem cells. International Journal of Molecular Medicine 39:1, pages 9-20.
Crossref
Crossref
Ye Feng, Shuohui Gao, Yongjian Gao, Xuefeng Wang & Zhi Chen. (2016) Anti-EGFR antibody sensitizes colorectal cancer stem-like cells to Fluorouracil-induced apoptosis by affecting autophagy. Oncotarget 7:49.
Crossref
Crossref
Otgontuya Sambuudash, Hee Man Kim, Hannah Jo, Hyun Sik Kim, Kyong Joo Lee, Hong Jun Park, Jae Woo Kim, Mee Yon Cho & Hyun-Soo Kim. (2016) Molecular characteristics of colorectal serrated polyps and hyperplastic polyps. Medicine 95:49, pages e5592.
Crossref
Crossref
Ke Xu, Ke Shen, Xin Liang, Yueqi Li, Norio Nagao, Jiyu Li, Jianwen Liu & Peihao Yin. (2016)
MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating
NOTCH1
in colorectal carcinoma cells
. Oncotarget 7:46, pages 75118-75129.
Crossref
Crossref
J. H. L. Neumann. (2016) Prognostische Biomarker für das metastasierte kolorektale KarzinomPrognostic biomarkers for metastatic colorectal cancer. Der Pathologe 37:S2, pages 180-185.
Crossref
Crossref
Karen Bento Ribeiro, Juliana da Silva Zanetti, Alfredo Ribeiro-Silva, Liane Rapatoni, Harley Francisco de Oliveira, Daniela Pretti da Cunha Tirapelli, Sergio Britto Garcia, Omar Feres, José Joaquim Ribeiro da Rocha & Fernanda Maris Peria. (2016) KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer. Cancer Biomarkers 16:4, pages 513-521.
Crossref
Crossref
Xing Wu, Fenlang Wu, Dongwen Xu & Tao Zhang. (2016) Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas. Journal of Neuro-Oncology 127:2, pages 221-232.
Crossref
Crossref
Yang Zhao, Jing Peng, Enlong Zhang, Ning Jiang, Jiang Li, Qi Zhang, Xuening Zhang & Yuanjie Niu. (2016) CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis. Oncotarget 7:9, pages 10023-10036.
Crossref
Crossref
Pasquale Zizza, Chiara Cingolani, Simona Artuso, Erica Salvati, Angela Rizzo, Carmen D'Angelo, Manuela Porru, Bruno Pagano, Jussara Amato, Antonio Randazzo, Ettore Novellino, Antonella Stoppacciaro, Eric Gilson, Giorgio Stassi, Carlo Leonetti & Annamaria Biroccio. (2016) Intragenic G-quadruplex structure formed in the human CD133 and its biological and translational relevance. Nucleic Acids Research 44:4, pages 1579-1590.
Crossref
Crossref
Jin-Yong Zhou, Min Chen, Long Ma, Xiaoxiao Wang, Yu-Gen Chen & Shen-Lin Liu. (2016) Role of CD44high/CD133high HCT-116 cells in the tumorigenesis of colon cancer. Oncotarget 7:7, pages 7657-7666.
Crossref
Crossref
Yalan Bi, Yunxiao Meng, Huanwen Wu, Quancai Cui, Yufeng Luo & Xiaowei Xue. (2016) Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis. Journal of Surgical Oncology 113:2, pages 144-151.
Crossref
Crossref
M. V. Puchinskaya. (2016) Cancer stem cell markers and their prognostic value. Arkhiv patologii 78:2, pages 47.
Crossref
Crossref
A. S. Chopra, X. Liu & H. Liu. 2016. Cancer Stem Cells. Cancer Stem Cells
341
366
.
Fatemeh B. Rassouli, Maryam M. Matin & Morvarid Saeinasab. (2015) Cancer stem cells in human digestive tract malignancies. Tumor Biology 37:1, pages 7-21.
Crossref
Crossref
Mei Guo & Jun Dou. (2015) Advances and perspectives of colorectal cancer stem cell vaccine. Biomedicine & Pharmacotherapy 76, pages 107-120.
Crossref
Crossref
Dae-Woon Eom, Seung-Mo Hong, Gwangil Kim, Young Kyung Bae, Kee-Taek Jang & Eunsil Yu. (2015) Prognostic Significance of CD44v6, CD133, CD166, and ALDH1 Expression in Small Intestinal Adenocarcinoma. Applied Immunohistochemistry & Molecular Morphology 23:10, pages 682-688.
Crossref
Crossref
Xiongzhi Wangpu, Xiao Yang, Jingkun Zhao, Jiaoyang Lu, Shaopei Guan, Jun Lu, Zaklina Kovacevic, Wensheng Liu, Lan Mi, Runsen Jin, Jing Sun, Fei Yue, Junjun Ma, Aiguo Lu, Des R. Richardson, Lishun Wang & Minhua Zheng. (2015)
The metastasis suppressor, NDRG1, inhibits “stemness” of colorectal cancer
via
down-regulation of nuclear β-catenin and CD44
. Oncotarget 6:32, pages 33893-33911.
Crossref
Crossref
Xintao Li, Xin Ma, Luyao Chen, Liangyou Gu, Yu Zhang, Fan Zhang, Yun Ouyang, Yu Gao, Qingbo Huang & Xu Zhang. (2015) Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis. Scientific Reports 5:1.
Crossref
Crossref
Marlies Michl, Volker Heinemann, Andreas Jung, Jutta Engel, Thomas Kirchner & Jens Neumann. (2015) Expression of cancer stem cell markers in metastatic colorectal cancer correlates with liver metastasis, but not with metastasis to the central nervous system. Pathology - Research and Practice 211:8, pages 601-609.
Crossref
Crossref
Azadeh Anbarlou, Amir Atashi, Masoud Soleimani, Mahshid AkhavanRahnama, Mahbobeh Bohloli & Majid Mossahebi-Mohammadi. (2015) Differential characteristics of CD133+ and CD133− Jurkat cells. In Vitro Cellular & Developmental Biology - Animal 51:6, pages 556-561.
Crossref
Crossref
FEIFENG JING, HUN JIN KIM, CHANG HYUN KIM, YOUNG JIN KIM, JAE HYUK LEE & HYEONG ROK KIM. (2015) Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases. International Journal of Oncology 46:4, pages 1582-1588.
Crossref
Crossref
Heather Dawson & Alessandro Lugli. (2015) Molecular and Pathogenetic Aspects of Tumor Budding in Colorectal Cancer. Frontiers in Medicine 2.
Crossref
Crossref
Danysh Abetov, Zhanar Mustapova, Timur Saliev & Denis Bulanin. (2015) Biomarkers and signaling pathways of colorectal cancer stem cells. Tumor Biology 36:3, pages 1339-1353.
Crossref
Crossref
Jerry Zhou, Larissa Belov, Pierre Chapuis, Charles Chan, Nicola Armstrong, Kimberley L. Kaufman, Michael J. Solomon, Stephen J. Clarke & Richard I. Christopherson. (2015) Surface profiles of live colorectal cancer cells and tumor infiltrating lymphocytes from surgical samples correspond to prognostic categories. Journal of Immunological Methods 416, pages 59-68.
Crossref
Crossref
Pratima Nangia-Makker, Yingjie Yu, Lulu Farhana, Kulsoom Ahmed & Adhip P. N. Majumdar. 2015. Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology. Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology
227
245
.
Paola Ferrari & Andrea Nicolini. 2015. Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology. Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology
13
66
.
Sung Hoon Sim, Mi-Hyun Kang, Yu Jung Kim, Keun-Wook Lee, Duck-Woo Kim, Sung-Bum Kang, Keun-Yong Eom, Jae-Sung Kim, Hye Seung Lee & Jee Hyun Kim. (2014) p21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer. BMC Cancer 14:1.
Crossref
Crossref
Qingli Li, Hongying Liu, Yiting Wang, Zhen Sun, Fangmin Guo & Jianzhong Zhu. (2014) Methyl green and nitrotetrazolium blue chloride co-expression in colon tissue: A hyperspectral microscopic imaging analysis. Optics & Laser Technology 64, pages 337-342.
Crossref
Crossref
Timothy L. Fitzgerald, Swathi Rangan, Larry Dobbs, Shane Starr & George Sigounas. (2014) The impact of Aldehyde dehydrogenase 1 expression on prognosis for metastatic colon cancer. Journal of Surgical Research 192:1, pages 82-89.
Crossref
Crossref
Liang Cao, Xiang Hu, Jian Zhang, Pin Liang & Yi Zhang. (2014)
CD44
+
CD324
−
expression and prognosis in gastric cancer patients
. Journal of Surgical Oncology 110:6, pages 727-733.
Crossref
Crossref
Ya‐Chin Hou, Ying‐Jui Chao, Hui‐Ling Tung, Hao‐Chen Wang & Yan‐Shen Shan. (2014) Coexpression of CD44‐positive/CD133‐positive cancer stem cells and CD204‐positive tumor‐associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma. Cancer 120:17, pages 2766-2777.
Crossref
Crossref
Laura Cernat, Cristina Blaj, Rene Jackstadt, Lydia Brandl, Jutta Engel, Heiko Hermeking, Andreas Jung, Thomas Kirchner & David Horst. (2014) Colorectal Cancers Mimic Structural Organization of Normal Colonic Crypts. PLoS ONE 9:8, pages e104284.
Crossref
Crossref
M Ozawa, Y Ichikawa, Y-W Zheng, T Oshima, H Miyata, K Nakazawa, H-B Guan, M Shiozawa, M Akaike, K Watanabe, M Ota, S Fujii, C Kunisaki, T Ishikawa, K Tanaka, H Akiyama, I Endo & H Taniguchi. (2014) Prognostic significance of CD44 variant 2 upregulation in colorectal cancer. British Journal of Cancer 111:2, pages 365-374.
Crossref
Crossref
Rebecca A. Rowehl, Stephanie Burke, Agnieszka B. Bialkowska, Donald W. Pettet, Leahana Rowehl, Ellen Li, Eric Antoniou, Yuanhao Zhang, Roberto Bergamaschi, Kenneth R. Shroyer, Iwao Ojima & Galina I. Botchkina. (2014) Establishment of Highly Tumorigenic Human Colorectal Cancer Cell Line (CR4) with Properties of Putative Cancer Stem Cells. PLoS ONE 9:6, pages e99091.
Crossref
Crossref
Jae Jun Park, Ji-hee Kwon, Sun-Hee Oh, Junjeong Choi, Chang Mo Moon, Joong Bae Ahn, Sung Pil Hong, Jae Hee Cheon, Tae Il Kim, Hoguen Kim & Won Ho Kim. (2014) Differential expression of CD133 based on microsatellite instability status in human colorectal cancer. Molecular Carcinogenesis 53:S1, pages E1-E10.
Crossref
Crossref
Fiorenza Lotti, Awad M. Jarrar, Rish K. Pai, Masahiro Hitomi, Justin Lathia, Adam Mace, Gerald A. GanttJr.Jr., Kumar Sukhdeo, Jennifer DeVecchio, Amit Vasanji, Patrick Leahy, Anita B. Hjelmeland, Matthew F. Kalady & Jeremy N. Rich. (2013) Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A. Journal of Experimental Medicine 210:13, pages 2851-2872.
Crossref
Crossref
Juanjuan Ou, Jia Deng, Xing Wei, Ganfeng Xie, Rongbin Zhou, Liqing Yu & Houjie Liang. (2013) Fibronectin extra domain A (EDA) sustains CD133+/CD44+ subpopulation of colorectal cancer cells. Stem Cell Research 11:2, pages 820-833.
Crossref
Crossref
Chao Ni, Zhigang Zhang, Xiaotao Zhu, Yang Liu, Dihong Qu, Ping Wu, Jian Huang & A-xiang Xu. (2013) Prognostic Value of CD166 Expression in Cancers of the Digestive System: A Systematic Review and Meta-Analysis. PLoS ONE 8:8, pages e70958.
Crossref
Crossref
Bo Jiang. (2013) Inhibition of the transcription factor Sp1 suppresses colon cancer stem cell growth and induces apoptosis in vitro and in nude mouse xenografts. Oncology Reports.
Crossref
Crossref
Flavia De Carlo, Theodore R. Witte, W. Elaine Hardman & Pier Paolo Claudio. (2013) Omega-3 Eicosapentaenoic Acid Decreases CD133 Colon Cancer Stem-Like Cell Marker Expression While Increasing Sensitivity to Chemotherapy. PLoS ONE 8:7, pages e69760.
Crossref
Crossref
S. Tuulia Avoranta, Eija A. Korkeila, Raija H. Ristamäki, Kari J. Syrjänen, Olli M. Carpén, Seppo O. Pyrhönen & Jari T.T. Sundström. (2013) ALDH1 expression indicates chemotherapy resistance and poor outcome in node-negative rectal cancer. Human Pathology 44:6, pages 966-974.
Crossref
Crossref
Amanda G. Hansen, Tanner J. Freeman, Shanna A. Arnold, Alina Starchenko, Celestial R. Jones-Paris, Michael A. Gilger, Mary K. Washington, Kang-Hsien Fan, Yu Shyr, Robert D. Beauchamp & Andries Zijlstra. (2013) Elevated ALCAM Shedding in Colorectal Cancer Correlates with Poor Patient Outcome. Cancer Research 73:10, pages 2955-2964.
Crossref
Crossref
Shradha S. Khurana, Terrence E. Riehl, Benjamin D. Moore, Matteo Fassan, Massimo Rugge, Judith Romero-Gallo, Jennifer Noto, Richard M. PeekJr.Jr., William F. Stenson & Jason C. Mills. (2013) The Hyaluronic Acid Receptor CD44 Coordinates Normal and Metaplastic Gastric Epithelial Progenitor Cell Proliferation. Journal of Biological Chemistry 288:22, pages 16085-16097.
Crossref
Crossref
Yusuke Shiozawa, Biao Nie, Kenneth J. Pienta, Todd M. Morgan & Russell S. Taichman. (2013) Cancer stem cells and their role in metastasis. Pharmacology & Therapeutics 138:2, pages 285-293.
Crossref
Crossref
Francesco Epifano, Salvatore Genovese, Rebecca Miller & Adhip P. N. Majumdar. (2013) Auraptene and its Effects on the Re-emergence of Colon Cancer Stem Cells. Phytotherapy Research 27:5, pages 784-786.
Crossref
Crossref
Timothy E. Andrews, Dan Wang & Daniel A. Harki. (2012) Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery. Drug Delivery and Translational Research 3:2, pages 121-142.
Crossref
Crossref
Maria-Elena Pad�n-Iruegas. (2013) Prognostic value of changes in the expression of stem cell markers in the peripheral blood of patients with colon cancer. Oncology Reports.
Crossref
Crossref
V Boncheva, S A Bonney, S E Brooks, M Tangney, G O'Sullivan, A Mirnezami & B-A Guinn. (2013) New targets for the immunotherapy of colon cancer—does reactive disease hold the answer?. Cancer Gene Therapy 20:3, pages 157-168.
Crossref
Crossref
Shicai Chen, Xinming Song, Zhihui Chen, Xinxin Li, Mingzhe Li, Haiying Liu & Jianchang Li. (2013) CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis. PLoS ONE 8:2, pages e56380.
Crossref
Crossref
Martin Canis, Axel Lechner, Brigitte Mack, Pamela Zengel, Rüdiger Paul Laubender, Udo Koehler, Vigo Heissmeyer & Olivier Gires. (2012) CD133 induces tumour-initiating properties in HEK293 cells. Tumor Biology 34:1, pages 437-443.
Crossref
Crossref
Philipp Grosse‐Gehling, Christine A Fargeas, Claudia Dittfeld, Yvette Garbe, Malcolm R Alison, Denis Corbeil & Leoni A Kunz‐Schughart. (2012) CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. The Journal of Pathology 229:3, pages 355-378.
Crossref
Crossref
Antonia Bellizzi, Sinto Sebastian, Pasquale Ceglia, Matteo Centonze, Rosa Divella, Elvira Foglia Manzillo, Amalia Azzariti, Nicola Silvestris, Severino Montemurro, Cosimo Caliandro, Raffaele De Luca, Giuseppe Cicero, Sergio Rizzo, Antonio Russo, Michele Quaranta, Giovanni Simone & Angelo Paradiso. (2012)
Co‐expression of CD133
+
/CD44
+
in human colon cancer and liver metastasis
. Journal of Cellular Physiology 228:2, pages 408-415.
Crossref
Crossref
Songmei Geng, Yuanyuan Guo, Qianqian Wang, Lan Li & Jianli Wang. (2012) Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial?mesenchymal transition in squamous cell carcinoma. Archives of Dermatological Research 305:1, pages 35-47.
Crossref
Crossref
Thilo Sprenger, Lena‐Christin Conradi, Tim Beissbarth, Heiko Ermert, Kia Homayounfar, Peter Middel, Josef Rüschoff, Hendrik A. Wolff, Philipp Schüler, B. Michael Ghadimi, Claus Rödel, Heinz Becker, Franz Rödel & Torsten Liersch. (2012) Enrichment of CD133‐expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival. Cancer 119:1, pages 26-35.
Crossref
Crossref
Claudio Coco, Gian Franco Zannoni, Emanuele Caredda, Stefano Sioletic, Alma Boninsegna, Mario Migaldi, Gianluca Rizzo, Luca Reggiani Bonetti, Giannicola Genovese, Egidio Stigliano, Achille Cittadini & Alessandro Sgambato. (2012) Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients. Journal of Experimental & Clinical Cancer Research 31:1.
Crossref
Crossref
Ke Wang, Jianjun Xu, Junshu Zhang & Jian Huang. (2012) Prognostic role of CD133 expression in colorectal cancer: a meta-analysis. BMC Cancer 12:1.
Crossref
Crossref
Boon Seng Soh, Dahai Zheng, Julie Su Li Yeo, Henry He Yang, Shi Yan Ng, Lan Hiong Wong, Wencai Zhang, Pin Li, Massimo Nichane, Atasha Asmat, Poo Sing Wong, Peng Cheang Wong, Lin Lin Su, Sakis A Mantalaris, Jia Lu, Wa Xian, Frank McKeon, Jianzhu Chen, Elaine Hsuen Lim & Bing Lim. (2012) CD166pos Subpopulation From Differentiated Human ES and iPS Cells Support Repair of Acute Lung Injury. Molecular Therapy 20:12, pages 2335-2346.
Crossref
Crossref
Susann Peickert, Julia Waurig, Claudia Dittfeld, Antje Dietrich, Yvette Garbe, Lydia Kabus, Michael Baumann, Marian Grade, Thomas Ried & Leoni A Kunz-Schughart. (2012) Rapid re-expression of CD133 protein in colorectal cancer cell lines in vitro and in vivo. Laboratory Investigation 92:11, pages 1607-1622.
Crossref
Crossref
Michael Tachezy, Hilke Zander, Florian Gebauer, Andreas Marx, Jussuf T. Kaifi, Jakob R. Izbicki & Maximilian Bockhorn. (2012) Activated leukocyte cell adhesion molecule (CD166)—Its prognostic power for colorectal cancer patients. Journal of Surgical Research 177:1, pages e15-e20.
Crossref
Crossref
Crist?bal Aguilar-Gallardo, Emily Cecilia Rutledge, Ana M. Mart?nez-Arroyo, Juan Jos? Hidalgo, Santiago Domingo & Carlos Sim?n. (2012) Overcoming Challenges of Ovarian Cancer Stem Cells: Novel Therapeutic Approaches. Stem Cell Reviews and Reports 8:3, pages 994-1010.
Crossref
Crossref
RALF KEMMERLING, BEATE ALINGER, OTTO DIETZE, HANS-CHRISTIAN BÖSMÜLLER, MATTHIAS OCKER, GERNOT W. WOLKERSDÖRFER, FRIEDER BERR, DANIEL NEUREITER & TOBIAS KIESSLICH. (2012) Association of stem cell marker expression pattern and survival in human biliary tract cancer. International Journal of Oncology 41:2, pages 511-522.
Crossref
Crossref
Michael Tachezy, Hilke Zander, Andreas H. Marx, Phillip R. Stahl, Florian Gebauer, Jakob R. Izbicki & Maximilian Bockhorn. (2012) ALCAM (CD166) Expression and Serum Levels in Pancreatic Cancer. PLoS ONE 7:6, pages e39018.
Crossref
Crossref
NIAN-HUA ZHANG, JIE LI, YIN LI, XIN-TAO ZHANG, WEN-TING LIAO, JUN-YI ZHANG, RONG LI & RONG-CHENG LUO. (2012) Co-expression of CXCR4 and CD133 proteins is associated with poor prognosis in stage II–III colon cancer patients. Experimental and Therapeutic Medicine 3:6, pages 973-982.
Crossref
Crossref
Kristel Kemper, Miranda Versloot, Katherine Cameron, Selçuk Colak, Felipe de Sousa e Melo, Joan H. de Jong, Joanne Bleackley, Louis Vermeulen, Rogier Versteeg, Jan Koster & Jan Paul Medema. (2012) Mutations in the Ras–Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer. Clinical Cancer Research 18:11, pages 3132-3141.
Crossref
Crossref
Xiaodong Huang, Yu Sheng & Ming Guan. (2012) Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis. Surgical Oncology 21:2, pages 103-107.
Crossref
Crossref
Remond J.A. Fijneman, Meike de Wit, Maral Pourghiasian, Sander R. Piersma, Thang V. Pham, Marc O. Warmoes, Mehrdad Lavaei, Chloe Piso, Fiona Smit, Pien M. Delis-van Diemen, Sietze T. van Turenhout, Jochim S. Terhaar sive Droste, Chris J.J. Mulder, Marinus A. Blankenstein, Els C. Robanus-Maandag, Ron Smits, Riccardo Fodde, Victor W.M. van Hinsbergh, Gerrit A. Meijer & Connie R. Jimenez. (2012) Proximal Fluid Proteome Profiling of Mouse Colon Tumors Reveals Biomarkers for Early Diagnosis of Human Colorectal Cancer. Clinical Cancer Research 18:9, pages 2613-2624.
Crossref
Crossref
Crystal J. Hessman, Emily J. Bubbers, Kevin G. Billingsley, Daniel O. Herzig & Melissa H. Wong. (2012) Loss of expression of the cancer stem cell marker aldehyde dehydrogenase 1 correlates with advanced-stage colorectal cancer. The American Journal of Surgery 203:5, pages 649-653.
Crossref
Crossref
Chih-Hung Lin, Wan-Tzu Chen, Chia-Hsing Liu, Hung-Pei Tsai, Chun-Chieh Wu & Chee-Yin Chai. (2012) Increased CD133 expression after preoperative chemoradiotherapy in rectal cancers other than mucin-rich tumors. Virchows Archiv 460:5, pages 447-453.
Crossref
Crossref
Ying-fei Li, Bing Xiao, San-fang Tu, Yuan-yuan Wang & Xiao-lang Zhang. (2012) Cultivation and identification of colon cancer stem cell-derived spheres from the Colo205 cell line. Brazilian Journal of Medical and Biological Research 45:3, pages 197-204.
Crossref
Crossref
Michael Jäger, Alexandra Schoberth, Peter Ruf, Juergen Hess, Michael Hennig, Barbara Schmalfeldt, Pauline Wimberger, Michael Ströhlein, Bettina Theissen, Markus M. Heiss & Horst Lindhofer. (2012) Immunomonitoring Results of a Phase II/III Study of Malignant Ascites Patients Treated with the Trifunctional Antibody Catumaxomab (Anti-EpCAM × Anti-CD3). Cancer Research 72:1, pages 24-32.
Crossref
Crossref
Ke-li Chen, Feng Pan, Heng Jiang, Jian-fang Chen, Li Pei, Fang-wei Xie & Hou-jie Liang. (2011) Highly enriched CD133+CD44+ stem-like cells with CD133+CD44high metastatic subset in HCT116 colon cancer cells. Clinical & Experimental Metastasis 28:8, pages 751-763.
Crossref
Crossref
SUNG-CHUL LIM & RAN HONG. (2011) Programmed cell death 4 (Pdcd4) expression in colorectal adenocarcinoma: Association with clinical stage. Oncology Letters 2:6, pages 1053-1057.
Crossref
Crossref
Armin Gerger, Wu Zhang, Dongyun Yang, Pierre Bohanes, Yan Ning, Thomas Winder, Melissa J. LaBonte, Peter M. Wilson, Leonor Benhaim, David Paez, Rita El-Khoueiry, Anthony El-Khoueiry, Michael Kahn & Heinz-Josef Lenz. (2011) Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence. Clinical Cancer Research 17:21, pages 6934-6943.
Crossref
Crossref
Monika Dzieciatkowska, Guihong Qi, Jinsam You, Kerry G. Bemis, Heather Sahm, Howard M. Lederman, Thomas O. Crawford, Lawrence M. Gelbert, Cynthia Rothblum-Oviatt & Mu Wang. (2011) Proteomic Characterization of Cerebrospinal Fluid from Ataxia-Telangiectasia (A-T) Patients Using a LC/MS-Based Label-Free Protein Quantification Technology. International Journal of Proteomics 2011, pages 1-13.
Crossref
Crossref
Danielle Langeveld, Marnix Jansen, Lodewijk Brosens, Folkert Morsink, G. Johan Offerhaus & Wendy de Leng. (2011) Diversity Counts. American Journal of Clinical Pathology 135:6, pages 878-888.
Crossref
Crossref
Simone Di Franco, Pietro Mancuso, Antonina Benfante, Marisa Spina, Flora Iovino, Francesco Dieli, Giorgio Stassi & Matilde Todaro. (2011) Colon Cancer Stem Cells: Bench-to-Bedside—New Therapeutical Approaches in Clinical Oncology for Disease Breakdown. Cancers 3:2, pages 1957-1974.
Crossref
Crossref
Amanda Hansen, Guido Swart & Andries Zijlstra. (2011) ALCAM. AfCS-Nature Molecule Pages.
Crossref
Crossref
Eric C. Anderson, Crystal Hessman, Trevor G. Levin, Marcus M. Monroe & Melissa H. Wong. (2011) The Role of Colorectal Cancer Stem Cells in Metastatic Disease and Therapeutic Response. Cancers 3:1, pages 319-339.
Crossref
Crossref
Mauro Biffoni, Eros Fabrizi & Lucia Ricci-Vitiani. 2011. Cancer Stem Cells in Solid Tumors. Cancer Stem Cells in Solid Tumors
57
78
.
Craig Gedye, Richard P. Hill & Laurie Ailles. 2011. Cancer Stem Cells in Solid Tumors. Cancer Stem Cells in Solid Tumors
433
464
.
Larissa Belov, Jerry Zhou & Richard I. Christopherson. (2010) Cell Surface Markers in Colorectal Cancer Prognosis. International Journal of Molecular Sciences 12:1, pages 78-113.
Crossref
Crossref
Sayantan Bhattacharya, George Mathew, Ernie Ruban, David B. A. Epstein, Andreas Krusche, Reyk Hillert, Walter Schubert & Michael Khan. (2010)
Toponome Imaging System:
In Situ
Protein Network Mapping in Normal and Cancerous Colon from the Same Patient Reveals More than Five-Thousand Cancer Specific Protein Clusters and Their Subcellular Annotation by Using a Three Symbol Code
. Journal of Proteome Research 9:12, pages 6112-6125.
Crossref
Crossref
Po Zhao, Yazhuo Li & Yali Lu. (2010) Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma. BMC Cancer 10:1.
Crossref
Crossref
Caroline Gahrton, Hareth Nahi, Monika Jansson, Ann Wallblom, Evren Alici, Tolga Sutlu, Jan Samuelsson & Gösta Gahrton. (2010) Constitutional inv(3) in myelodysplastic syndromes. Leukemia Research 34:12, pages 1627-1629.
Crossref
Crossref
Xiao-Feng Le, Omar Merchant, Robert C. BastJr.Jr. & George A. Calin. (2010) The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade. Cancer Microenvironment 3:1, pages 137-147.
Crossref
Crossref
Xiaolong WeiDavid Dombkowski, Katia MeirellesRafael Pieretti-VanmarckePaul P. SzotekHenry L. ChangFrederic I. Preffer, Peter R. Mueller, Jose Teixeira, David T. MacLaughlinPatricia K. Donahoe. (2010) Müllerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics. Proceedings of the National Academy of Sciences 107:44, pages 18874-18879.
Crossref
Crossref
Po Zhao, Yali Lu & Weidong Han. (2010) Clinicopathological significance and prognostic value of leukemia-related protein 16 expression in invasive ductal breast carcinoma. Cancer Science 101:10, pages 2262-2268.
Crossref
Crossref
Guangqiu Li, Chao Liu, Jian Yuan, Xiaoqin Xiao, Na Tang, Junmei Hao, Hongwei Wang, Xiuwu Bian, Yongjian Deng & Yanqing Ding. (2010) CD133+ single cell-derived progenies of colorectal cancer cell line SW480 with different invasive and metastatic potential. Clinical & Experimental Metastasis 27:7, pages 517-527.
Crossref
Crossref
A Lugli, G Iezzi, I Hostettler, M G Muraro, V Mele, L Tornillo, V Carafa, G Spagnoli, L Terracciano & I Zlobec. (2010) Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. British Journal of Cancer 103:3, pages 382-390.
Crossref
Crossref
Julie M Chandler & Eric Lagasse. (2010) Cancerous stem cells: deviant stem cells with cancer-causing misbehavior. Stem Cell Research & Therapy 1:2.
Crossref
Crossref
Motohiro Kojima, Genichiro Ishii, Naho Atsumi, Yuji Nishizawa, Norio Saito & Atsushi Ochiai. (2009) CD133 expression in rectal cancer after preoperative chemoradiotherapy. Cancer Science 101:4, pages 906-912.
Crossref
Crossref
Chee W Ong, Lay G Kim, Hui H Kong, Lai Y Low, Barry Iacopetta, Richie Soong & Manuel Salto-Tellez. (2010) CD133 expression predicts for non-response to chemotherapy in colorectal cancer. Modern Pathology 23:3, pages 450-457.
Crossref
Crossref